Russell William Jenkins

21PUBLICATIONS
217CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Feb 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.

Janina Dörr, Lisa Gregor, Sebastian B Lacher

|Dec 03, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TIL.

Hongyan Xie, Aiping Jiang, Aonkon Dey

|Sep 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapy.

Jung-Ho Chun, Birkley S Lim, Suyasha Roy

|Jun 13, 2025
Patient-derived organotypic tumor spheroids, tumoroids, and organoids: advancing immunotherapy using state-of-the-art 3D tumor model systems.

David J Bozym, David X Zheng, Or-Yam Revach

Pageof 4

Frequent Collaborators

6 joint publications

Genevieve M Boland

4 joint publications

Yi Sun

3 joint publications

Keith T Flaherty

3 joint publications

Aleigha R Lawless